SRN Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$727K Buy
4,563
+268
+6% +$43.7K 0.66% 69
2025
Q1
$732K Sell
4,295
-134
-3% -$22.4K 0.82% 60
2024
Q4
$743K Sell
4,429
-1,487
-25% -$253K 0.66% 83
2024
Q3
$1.02M Sell
5,916
-281
-5% -$47.7K 0.91% 52
2024
Q2
$1.02M Hold
6,197
0.85% 52
2024
Q1
$1.01M Buy
6,197
+268
+5% +$42K 0.78% 69
2023
Q4
$869K Buy
+5,929
New +$878K 0.78% 65
2021
Q4
Sell
-5,923
Closed -$828K 124
2021
Q3
$828K Sell
5,923
-3,330
-36% -$472K 0.38% 67
2021
Q2
$1.25M Sell
9,253
-605
-6% -$81.9K 0.42% 82
2021
Q1
$1.34M Sell
9,858
-1,600
-14% -$209K 0.48% 79
2020
Q4
$1.58M Buy
+11,458
New +$1.6M 0.78% 75

Other funds holding PG

SRN Advisors's PG Position: Q2 2025 in Review

SRN Advisors increased its Procter & Gamble (PG) stake by 6.2% in Q2 2025, buying an estimated $43.7K and bringing the position to 4,563 shares worth $727K. The position accounts for 0.66% of the portfolio, ranked #69.

SRN Advisors first reported a position in PG in Q4 2020 and has held it in 11 quarters since. The position peaked at $1.58M in Q4 2020. 3,953 funds tracked by Wall St. Rank hold PG as of Q2 2025.

  • SRN Advisors held 4,563 shares of Procter & Gamble worth $727K as of Q2 2025.
  • SRN Advisors bought 268 Procter & Gamble shares in Q2 2025, an estimated $43.7K.
  • Procter & Gamble made up 0.66% of SRN Advisors's portfolio in Q2 2025, its #69 holding.
  • SRN Advisors first reported a position in Procter & Gamble in Q4 2020 and has held it in 11 quarters since.
  • SRN Advisors's Procter & Gamble position peaked at $1.58M in Q4 2020.
  • 3,953 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2025.

Based on SRN Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.